These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. MicroRNA-625-3p promotes cell migration of oral squamous cell carcinoma by regulating SCAI expression. Xu D; Gu M; Liu HL Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):641-648. PubMed ID: 30720172 [TBL] [Abstract][Full Text] [Related]
3. hsa_circ_0072387 Suppresses Proliferation, Metastasis, and Glycolysis of Oral Squamous Cell Carcinoma Cells by Downregulating miR-503-5p. Han L; Cheng J; Li A Cancer Biother Radiopharm; 2021 Feb; 36(1):84-94. PubMed ID: 32302508 [No Abstract] [Full Text] [Related]
4. MiR-455-5p suppresses PDZK1IP1 to promote the motility of oral squamous cell carcinoma and accelerate clinical cancer invasion by regulating partial epithelial-to-mesenchymal transition. Hsiao SY; Weng SM; Hsiao JR; Wu YY; Wu JE; Tung CH; Shen WL; Sun SF; Huang WT; Lin CY; Chen SH; Hong TM; Chen YL; Chang JY J Exp Clin Cancer Res; 2023 Feb; 42(1):40. PubMed ID: 36737832 [TBL] [Abstract][Full Text] [Related]
5. MiR-148a inhibits oral squamous cell carcinoma progression through ERK/MAPK pathway via targeting IGF-IR. Jia T; Ren Y; Wang F; Zhao R; Qiao B; Xing L; Ou L; Guo B Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32202300 [TBL] [Abstract][Full Text] [Related]
6. CDH4 suppresses the progression of salivary adenoid cystic carcinoma via E-cadherin co-expression. Xie J; Feng Y; Lin T; Huang XY; Gan RH; Zhao Y; Su BH; Ding LC; She L; Chen J; Lin LS; Lin X; Zheng DL; Lu YG Oncotarget; 2016 Dec; 7(50):82961-82971. PubMed ID: 27783992 [TBL] [Abstract][Full Text] [Related]
7. miR-146b Functions as an Oncogene in Oral Squamous Cell Carcinoma by Targeting HBP1. Li K; Zhou Z; Li J; Xiang R Technol Cancer Res Treat; 2020; 19():1533033820959404. PubMed ID: 33327874 [TBL] [Abstract][Full Text] [Related]
8. Knockdown of lncRNA IGF2BP2-AS1 inhibits proliferation and migration of oral squamous cell carcinoma cells via the Wnt/β-catenin pathway. Tong S; Wang X; Guo X; Lu Z J Oral Pathol Med; 2022 Mar; 51(3):272-280. PubMed ID: 34637162 [TBL] [Abstract][Full Text] [Related]
9. MiR-373 promotes proliferation and metastasis of oral squamous cell carcinoma by targeting SPOP. Zhang XJ; Jin Y; Song JL; Deng F Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5270-5276. PubMed ID: 31298378 [TBL] [Abstract][Full Text] [Related]
10. Inactivation of homeodomain-interacting protein kinase 2 promotes oral squamous cell carcinoma metastasis through inhibition of P53-dependent E-cadherin expression. Zheng X; Pan Y; Chen X; Xia S; Hu Y; Zhou Y; Zhang J Cancer Sci; 2021 Jan; 112(1):117-132. PubMed ID: 33063904 [TBL] [Abstract][Full Text] [Related]
11. miR-146a promotes proliferation, invasion, and epithelial-to-mesenchymal transition in oral squamous carcinoma cells. Wang F; Ye LJ; Wang FJ; Liu HF; Wang XL Environ Toxicol; 2020 Oct; 35(10):1050-1057. PubMed ID: 32469461 [TBL] [Abstract][Full Text] [Related]
12. LncRNA MINCR activates Wnt/β-catenin signals to promote cell proliferation and migration in oral squamous cell carcinoma. Lyu Q; Jin L; Yang X; Zhang F Pathol Res Pract; 2019 May; 215(5):924-930. PubMed ID: 30777615 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-504 functions as a tumor suppressor in oral squamous cell carcinoma through inhibiting cell proliferation, migration and invasion by targeting CDK6. Wang X; Chang K; Gao J; Wei J; Xu G; Xiao L; Song G Int J Biochem Cell Biol; 2020 Feb; 119():105663. PubMed ID: 31812760 [TBL] [Abstract][Full Text] [Related]
14. High expression of Rab31 confers a poor prognosis and enhances cell proliferation and invasion in oral squamous cell carcinoma. Li X; Zhu F; Liu Z; Tang X; Han Y; Jiang J; Ma C; He Y Oncol Rep; 2021 Mar; 45(3):1182-1192. PubMed ID: 33469675 [TBL] [Abstract][Full Text] [Related]
15. HMG20A was identified as a key enhancer driver associated with DNA damage repair in oral squamous cell carcinomas. Na L; Meijie Z; Wenjing Z; Bing Z; Yanhao D; Shanshan L; Yongle Q BMC Oral Health; 2022 Nov; 22(1):473. PubMed ID: 36335317 [TBL] [Abstract][Full Text] [Related]
16. The serum biomarker chemerin promotes tumorigenesis and metastasis in oral squamous cell carcinoma. Lu Z; Liang J; He Q; Wan Q; Hou J; Lian K; Wang A Clin Sci (Lond); 2019 Mar; 133(5):681-695. PubMed ID: 30804218 [TBL] [Abstract][Full Text] [Related]
17. Dysregulation of FOXD2-AS1 promotes cell proliferation and migration and predicts poor prognosis in oral squamous cell carcinoma: a study based on TCGA data. Liu Z; Zhou W; Lin C; Wang X; Zhang X; Zhang Y; Yang R; Chen W; Cao W Aging (Albany NY); 2020 Dec; 13(2):2379-2396. PubMed ID: 33318296 [TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA PVT1 promotes tumor cell proliferation, invasion, migration and inhibits apoptosis in oral squamous cell carcinoma by regulating miR‑150‑5p/GLUT‑1. Li X; Ren H Oncol Rep; 2020 Oct; 44(4):1524-1538. PubMed ID: 32945498 [TBL] [Abstract][Full Text] [Related]
19. Role of hyaluronan mediated motility receptor gene in oral squamous cell carcinoma and clinical prognosis. Tang Y; Xiao Y; Liao R Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 46(12):1315-1324. PubMed ID: 35232899 [TBL] [Abstract][Full Text] [Related]
20. CD47-SIRPα Signaling Induces Epithelial-Mesenchymal Transition and Cancer Stemness and Links to a Poor Prognosis in Patients with Oral Squamous Cell Carcinoma. Pai S; Bamodu OA; Lin YK; Lin CS; Chu PY; Chien MH; Wang LS; Hsiao M; Yeh CT; Tsai JT Cells; 2019 Dec; 8(12):. PubMed ID: 31861233 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]